Leukemic Phase of Non-Hodgkin Lymphoma — Trials

Leukemic Phase of Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04541017	Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment	terminated	Phase 1 / Phase 2	8	National Cancer Institute (NCI)NIH	1	Oct 16, 2025	clinicaltrials
NCT05879458	Ritlecitinib in CTCL	terminated	Phase 2	7	Icahn School of Medicine at Mount SinaiOTHER	1	Jul 18, 2025